These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4427990)

  • 21. The effects of scopolamine on fixed-interval behaviour in the rat: a rate-dependency effect.
    McKim WA
    Psychopharmacologia; 1973 Sep; 32(3):255-64. PubMed ID: 4762233
    [No Abstract]   [Full Text] [Related]  

  • 22. Scopolamine and benzodiazepine models of dementia: cross-reversals by Ro 15-1788 and physostigmine.
    Preston GC; Ward C; Lines CR; Poppleton P; Haigh JR; Traub M
    Psychopharmacology (Berl); 1989; 98(4):487-94. PubMed ID: 2570433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of pretrial and posttrial administration of cholinergic and anticholinergic drugs on spontaneous alternation.
    Squire LR
    J Comp Physiol Psychol; 1969 Sep; 69(1):69-75. PubMed ID: 5347369
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of 4-(o-benzylphenoxy)-N-methylbutylamine hydrochloride (MCI-2016) on the scopolamine-induced deficit of spontaneous alternation behavior in rats.
    Tobe A; Egawa M; Nagai R
    Jpn J Pharmacol; 1983 Aug; 33(4):775-84. PubMed ID: 6685201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perceptual bisection in rats: the effects of physostigmine, scopolamine and pirenzepine.
    Shurtleff D; Raslear TG; Genovese RF; Simmons L
    Physiol Behav; 1992 Feb; 51(2):381-90. PubMed ID: 1557449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The facilitation of discrimination performance by physostigmine sulphate.
    Warburton DM; Brown K
    Psychopharmacologia; 1972; 27(3):275-84. PubMed ID: 4642467
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of apomorphine and its interaction with other drugs in the domestic fowl.
    Osuide G; Adejoh PO
    Eur J Pharmacol; 1973 Jul; 23(1):56-66. PubMed ID: 4739056
    [No Abstract]   [Full Text] [Related]  

  • 28. On the acute effect of scopolamine and physostigmine on verbal associations.
    Hrbek J; Komenda S; Macáková J; Siroká A
    Act Nerv Super (Praha); 1970; 12(3):273-6. PubMed ID: 5457457
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of physostigmine and scopolamine on operant brightness discrimination in the rat.
    Leaton RN; Kreindler M
    Physiol Behav; 1972 Jul; 9(1):121-3. PubMed ID: 5080149
    [No Abstract]   [Full Text] [Related]  

  • 30. Cholinergic and anticholinergic influences on amphetamine-induced stereotyped behavior.
    Klawans HL; Rubovits R; Patel BC; Weiner WJ
    J Neurol Sci; 1972 Nov; 17(3):303-8. PubMed ID: 4653965
    [No Abstract]   [Full Text] [Related]  

  • 31. Assessment of working memory in rats using spatial alternation behavior with variable retention intervals: effects of fixed-ratio size and scopolamine.
    Shannon HE; Bemis KG; Hart JC
    Psychopharmacology (Berl); 1990; 100(4):491-7. PubMed ID: 2320710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Active avoidance behavior in guinea pigs: effects of physostigmine and scopolamine.
    Philippens IH; Melchers BP; Wolthuis OL
    Pharmacol Biochem Behav; 1992 Jun; 42(2):285-9. PubMed ID: 1631181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of antagonists of physostigmine-induced suppression of behavior.
    Vaillant GE
    J Pharmacol Exp Ther; 1967 Sep; 157(3):636-48. PubMed ID: 4963332
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of mutual interaction of scopolamine and its antidote physostigmine upon formation of free ammonia in experiment in vitro.
    Dostálová K; Hrbek J
    Act Nerv Super (Praha); 1973 May; 15(2):129. PubMed ID: 4752653
    [No Abstract]   [Full Text] [Related]  

  • 35. Interaction of scopolamine with physostigmine on EEG in man.
    Kolarík J; Hrbek J; Hrbek V; Waberăinek G
    Act Nerv Super (Praha); 1970; 12(3):278. PubMed ID: 5457459
    [No Abstract]   [Full Text] [Related]  

  • 36. Assessment of a combination of physostigmine and scopolamine as pretreatment against the behavioural effects of organophosphates in the common marmoset (Callithrix jacchus).
    Muggleton NG; Bowditch AP; Crofts HS; Scott EA; Pearce PC
    Psychopharmacology (Berl); 2003 Mar; 166(3):212-20. PubMed ID: 12589520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Separating the effects of response rate and reinforcement frequency in the rate-dependent effects of amphetamine and scopolamine on the schedule-controlled performance of rats and pigeons.
    MacPhail RC; Gollub LR
    J Pharmacol Exp Ther; 1975 Aug; 194(2):332-42. PubMed ID: 1151762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversal by tetrahydroaminoacridine of scopolamine-induced memory and performance deficits in rats.
    Murray TK; Cross AJ; Green AR
    Psychopharmacology (Berl); 1991; 105(1):134-6. PubMed ID: 1745706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antagonism of physostigmine induced lethality by a combination of scopolamine and methscopolamine.
    Janowsky DS; Berkowitz A; Turken A; Risch SC
    Acta Pharmacol Toxicol (Copenh); 1985 Feb; 56(2):154-7. PubMed ID: 3993383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of scopolamine and pilocarpine upon the aversive threshold of the rat.
    Houser VP; Van Hart DA
    Pharmacol Biochem Behav; 1973; 1(4):427-31. PubMed ID: 4777579
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.